A. Scanni

1.9k citations
50 papers · 1.3k · 1 hit paper · h-index 17

Impact in

  • Oncology top 5%
    • Lung Cancer Research Studies
    • Cancer Treatment and Pharmacology
    • Colorectal Cancer Treatments and Studies
    • HER2/EGFR in Cancer Research
    • Breast Cancer Treatment Studies

Papers in

    • Cancer Treatment and Pharmacology 11
    • Colorectal Cancer Treatments and Studies 5
    • Lung Cancer Research Studies 5
    • Lung Cancer Treatments and Mutations 7
    • Lung Cancer Diagnosis and Treatment 4
    • Gastric Cancer Management and Outcomes 3

A. Scanni

47 papers receiving 1.3k citations

A. Scanni's Hit Papers

Erlotinib versus docetaxel as second-line treatment of patients with advanced non-small-cell lung cancer and wild-type EGFR tumours (TAILOR): a randomised controlled trial 2013 · 381 citations
3810+4+8Years since publication100200300

Peers

A. Scanni
Comparison fields: 5 of 83
  • Oncology 617
  • Cancer Research 292
  • Pulmonary and Respiratory Medicine 473
  • Emergency Medical Services 89
  • Neurology 83
Replace Gabriella Farina with:
Gabriella Farina Italy
Nurullah Zengin Türkiye
Howard Silberman United States
Charles M. Bagley United States
Timothy J. Littlewood United Kingdom
Serge Benayoun Canada
Hikmat Abdel‐Razeq Jordan
Christina E. Bailey United States
María Eberg Canada
Jean‐Didier Grangé France
A. Scanni relative to Gabriella Farina Italy Gabriella Farina's profile →
Citations per field
00.5×1.5×1.8×
Gabriella Farina · 1×
Citations per year

Countries citing papers authored by A. Scanni

Since Specialization
Citations

This map shows the geographic impact of A. Scanni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Scanni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Scanni more than expected).

Fields of papers citing papers by A. Scanni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Scanni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Scanni. The network helps show where A. Scanni may publish in the future.

Co-authors

The 25 scholars most cited alongside A. Scanni, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with A. Scanni Line = papers co-authored together A. Scanni links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 50 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Erlotinib versus docetaxel as second-line treatment of patients with advanced non-small-cell lung cancer and wild-type EGFR tumours (TAILOR): a randomised controlled trial
Hit paper breakdown →
2013381
2 2003155
3 1999101
4 199081
5 202073
6 200759
7 200248
8 201244
9 197739
10 198436
11 199336
12 199325
13 200523
14 201222
15 200418
16 197916
17 199316
18 198814
19 201414
20 201113

About A. Scanni

A. Scanni is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Surgery and Pathology and Forensic Medicine, having authored 50 papers that have together received 1.3k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (11 papers), Breast Cancer Treatment Studies (8 papers), Lung Cancer Treatments and Mutations (7 papers), Colorectal Cancer Treatments and Studies (5 papers), Lung Cancer Research Studies (5 papers), Lung Cancer Diagnosis and Treatment (4 papers), Estrogen and related hormone effects (3 papers) and Gastric Cancer Management and Outcomes (3 papers). The work is most often cited by research in Oncology (617 citations), Cancer Research (292 citations), Pulmonary and Respiratory Medicine (473 citations), Emergency Medical Services (89 citations) and Neurology (83 citations). A. Scanni has collaborated with scholars based in Italy, Malaysia and United States. Frequent co-authors include M. Tomirotti, Gabriella Farina, Marina Chiara Garassino, Olga Martelli, Roberto Labianca, Irene Floriani, Monica Ganzinelli, Flavia Longo, Anna Bettini and Calogero Lauricella. Their work appears in journals such as Journal of Clinical Oncology, European Journal of Cancer, The Lancet Oncology, Cancer and Transplant International.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact